摘要 |
A medicament useful for preventive and/or therapeutic treatment of nerve system diseases which comprises, as an active ingredient, a compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof: wherein, X represents a group represented by the following general formula (II), (III), (IV), (V), or (VI), "A" represents a saturated or unsaturated 3- to 6-membered carbocyclic group and the like, "B" represents CH<SUB>2 </SUB>and the like, "n" represents 0 to 2, R<SUP>1 </SUP>represents a hydrogen atom, a halogen atom and the like, R<SUP>2</SUP>, R<SUP>3</SUP>, and R<SUP>7 </SUP>to R<SUP>14 </SUP>represent a hydrogen atom, a lower alkyl group which may be substituted and the like, R<SUP>4 </SUP>represents a hydrogen atom, a lower alkyl group which may be substituted and the like, R<SUP>5 </SUP>represents a hydrogen atom, a halogen atom and the like, R<SUP>6 </SUP>represents a saturated or unsaturated monocyclic or bicyclic carbocyclic group and the like, and R<SUP>5 </SUP>and R<SUP>6</SUP>, R<SUP>7 </SUP>and R<SUP>8</SUP>, R<SUP>9 </SUP>and R<SUP>10</SUP>, or R<SUP>11 </SUP>and R<SUP>12 </SUP>may bind to each other to form a cyclic structure.
|